STOCK TITAN

Thomas J. Catinazzo sells 15,515 shares (NASDAQ: RLAY) in Form 144

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Thomas J. Catinazzo reported sales of company common stock. The filing lists two dispositions: 13,820 shares for $105,308.40 on 01/27/2026 and 1,695 shares for $14,322.75 on 01/28/2026. The record also lists Restricted Stock Units dated 01/27/2025 as securities to be sold.

Positive

  • None.

Negative

  • None.

Insights

Reported insider dispositions of common stock in normal transactional detail.

The filing documents two specific dispositions by Thomas J. Catinazzo totaling 15,515 shares and aggregate proceeds of $119,630.15 across two dates: 01/27/2026 and 01/28/2026.

These entries are routine reporting of insider sales; cash‑flow treatment and any trading plan reference are not shown in the excerpt. Subsequent filings or broker confirmations would show execution mechanics if required.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What did Thomas J. Catinazzo report in the Form 144 for RLAY?

He reported two share dispositions totaling 15,515 shares and $119,630.15 in proceeds. The filing lists sales of 13,820 shares for $105,308.40 on 01/27/2026 and 1,695 shares for $14,322.75 on 01/28/2026.

Does the filing show any securities planned for sale by the issuer?

The filing lists Restricted Stock Units dated 01/27/2025 as securities to be sold. The excerpt labels these as "Restricted Stock Units" with the date 01/27/2025, but it does not state quantities or sale mechanics for those RSUs.

What dates and amounts are shown for the reported transactions?

Two transaction dates are shown: 01/27/2026 and 01/28/2026. On 01/27/2026 13,820 shares were reported at $105,308.40; on 01/28/2026 1,695 shares were reported at $14,322.75, per the excerpt.

Does this Form 144 indicate who received the sale proceeds?

The excerpt does not specify who received proceeds. The entries list the reporting person and amounts; the filing text does not state the recipient of cash or whether proceeds were paid to the issuer or selling holder.
Relay Therapeutics, Inc.

NASDAQ:RLAY

View RLAY Stock Overview

RLAY Rankings

RLAY Latest News

RLAY Latest SEC Filings

RLAY Stock Data

1.79B
145.72M
Biotechnology
Biological Products, (no Diagnostic Substances)
Link
United States
CAMBRIDGE